Effects of Retinoid and Phenylacetate Compounds on Neuroblastoma Cells
Author Information
Author(s): Sidell N, Pasquali M, Malkapuram S, Barua A B, Wanichkul T, Wada R K
Primary Institution: Emory University School of Medicine
Hypothesis
Can retinoid and phenylacetate compounds serve as effective, nontoxic alternatives for treating neuroblastoma?
Conclusion
The study demonstrates that a combination of retinoid and phenylacetate compounds can inhibit neuroblastoma tumor development and growth in a less toxic manner.
Supporting Evidence
- Retinoids have been shown to enhance differentiation in neuroblastoma cells.
- Combination treatments with phenylacetate and retinoids resulted in significant tumor growth inhibition.
- Long-term administration of retinoid compounds showed reduced toxicity compared to traditional treatments.
Takeaway
This study shows that certain medicines can help treat a type of cancer in kids without making them sick.
Methodology
The study involved in vitro and in vivo experiments using human neuroblastoma cells and mice to assess the effects of retinoid and phenylacetate treatments.
Potential Biases
Potential bias in the selection of treatment protocols and animal models used.
Limitations
The study primarily focused on specific compounds and may not account for all potential treatment options or long-term effects.
Participant Demographics
The study involved human neuroblastoma cells and athymic nude mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website